Proj3:Role of cytochrome P450 (CYP)1A/1B1 enzymes in the potentiation of neonatal lung injury in newbron mice exposed prenatally to PHs, and increased risk of premature infants to chronic lung disease
Proj3:Role of cytochrome P450 (CYP)1A/1B1 enzymes in the potentiation of neonatal lung injury in newbron mice exposed prenatally to PHs, and increased risk of premature infants to chronic lung disease
批准号:
10116394
负责人:
BHAGAVATULA MOORTHY
金额:
$36.09万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-28 至 2025-01-31
关键词:
A549AgeAirAlveolarAnimalsAnthracenesAromatic HydrocarbonsAromatic Polycyclic HydrocarbonsAspirate substanceBenzo(a)pyreneBiological AssayBirth RateBronchopulmonary DysplasiaCYP11A1 geneCYP1A1 geneCarcinogensCellsChemosensitizationChronic lung diseaseClinicalCollaborationsCorn OilCytochrome P450DNADNA AdductsDNA lesionDataDetectionDoseEZH2 geneEnvironmental HealthEnzymesEpigenetic ProcessEtiologyExhibitsExposure toGenesHumanHyperoxiaIn VitroInfantInosine DiphosphateLeadLifeLungMass FragmentographyMelissaMethylationMolecularMorbidity - disease rateMothersMusNeurocognitive DeficitNewborn InfantOralOutcomeOxygenParentsPathway interactionsPlacentaPrecision HealthPredispositionPregnancyPregnant WomenPremature BirthPremature InfantPreventionPrevention strategyPyrenesRUNX3 geneResearch SupportRetrospective StudiesRiskRoleSiteTestingToxic effectToxicity AttenuationUmbilical Cord BloodWalkersWeaningWild Type MouseWomanearly life exposureepigenomicsexperimental studyexposed human populationgenotoxicityhigh riskin vivoinsightlung injuryneonatal lung injuryneonatal miceneonateneurobehavioralneurobehavioral testnovel strategiespostnatalpregnantprematureprenatalprenatal exposurepreterm newbornpreventprofessorremediationsample archivesuperfund sitesupplemental oxygentranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Pregnant women, living in the vicinity of superfund sites, who may be exposed to polyclic
aromatic hydrocarbons (PAHs) that emanate from these sites, are at a higher risk for preterm
delivery. Preterm delivery requires the neonate to be subjected to supplemental oxygen
(hyperoxia), and this in turn could lead to chronic lung disease/ bronchopulmonary dysplasia
(BPD). We hypothesize that prenatal PAH exposure will exacerbate the effects of postnatal
supplemental oxygen in preterm neonates. The mechanisms by which PAHs potentiate BPD in
infants are not well understood. The central hypothesis of this project is that prenatal
administration of PAHs [i.e. benzo[a]pyrene (BP), or a mixture of benzo(a)pyrene (BP),
benzo(b)fluoranthrene (BbF), and dibenz[a]anthracene (DBA)], which are which are defined as
class B2 carcinogens by USEPA, will differentially exacerbate lung injury and alveolar
simplification in neonatal mice following postnatal hyperoxia, and that this effect will be altered in
mice lacking the gene for cytochrome P450 (Cyp)1a1 or 1a2 genes by mechanisms entailing a
combination of genotoxic and epigenetic mechanisms. We will also test the hypothesis that the
infants exposed prenatally to PAHs have a greater risk of developing BPD than those exposed to
lesser or no PAHs, and that human pulmonary cells exposed to remediated PAHs will exhibit
lesser toxicity than parent PAHs. In order to test these hypotheses, we propose the following Specific
Aims: (1). Specific Aim 1. To test the hypothesis that prenatal exposure of wild type (WT) (C57BL/6J)
mice to the PAH BP or a mixture of PAHs (BP + BbF + DBA) will result in exacerbation of lung injury and
alveolar simplification following postnatal hyperoxia, and this effect will be altered in mice lacking the gene
for Cyp1a1, 1a2 or 1b1. 2. To determine the mechanisms by which prenatal PAHs will alter the
susceptibility of neonatal mice to hyperoxia. 3. To test the hypothesis that mothers exposed to
PAHs (that are present in superfund sites) are at a greater risk for preterm delivery, and that these
infants will show increased susceptibility to develop BPD than those with lesser or no exposure.
Accomplishments of these aims could lead to novel strategies for the prevention/treatment in
premature infants of BPD, which is probably potentiated by maternal PAHs that emanate from
Superfund sites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of exacerbation of COVID-19 pathogenesis in mice expressing human ACE2 by polycyclic aromatic hydrocarbons (PAHs), and its protection by inhibition of soluble epoxide hydrolase (sEH)
-
批准号:10156460
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2021
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Mechanisms of exacerbation of COVID-19 pathogenesis in mice expressing human ACE2 by polycyclic aromatic hydrocarbons (PAHs), and its protection by inhibition of soluble epoxide hydrolase (sEH)
-
批准号:10337295
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2021
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION, EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONIC LUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION AND REMEDIATION
-
批准号:10401127
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Proj3:Role of cytochrome P450 (CYP)1A/1B1 enzymes in the potentiation of neonatal lung injury in newbron mice exposed prenatally to PHs, and increased risk of premature infants to chronic lung disease
-
批准号:10559705
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION, EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONIC LUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION AND REMEDIATION
-
批准号:10382017
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Core A: Administrative and Research Translation Core (ARTC)
-
批准号:10116385
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION, EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONIC LUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION AND REMEDIATION
-
批准号:10559666
-
项目类别:
-
资助金额:$175.1万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Core A: Administrative and Research Translation Core (ARTC)
-
批准号:10559668
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
POLYCYCLIC AROMATIC HYDROCARBONS: ULTRASENSITIVE DETECTION, EARLY LIFE EXPOSURES-CLINICAL OUTCOMES (PRETERM BIRTHS, CHRONIC LUNG DISEASE, AND NEUROCOGNITIVE DEFICITS), PREVENTION AND REMEDIATION
-
批准号:10116383
-
项目类别:
-
资助金额:$175.1万
-
财政年份:2020
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Mechanistic role of P4501 enzymes in the prevention of PAH carcinogenesis by omega 3 fatty acids
-
批准号:10163846
-
项目类别:
-
资助金额:$45.14万
-
财政年份:2018
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Mechanistic role of P4501 enzymes in the prevention of PAH carcinogenesis by omega 3 fatty acids
-
批准号:10404072
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2018
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Mechanistic roles of Cytochrome P4501A enzymes in hyperoxic lung injury
-
批准号:9127549
-
项目类别:
-
资助金额:$54.03万
-
财政年份:2016
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
-
批准号:8786596
-
项目类别:
-
资助金额:$57.1万
-
财政年份:2012
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
-
批准号:8603280
-
项目类别:
-
资助金额:$57.06万
-
财政年份:2012
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
-
批准号:8255907
-
项目类别:
-
资助金额:$60.14万
-
财政年份:2012
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDS
-
批准号:8403926
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2012
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury
-
批准号:8204511
-
项目类别:
-
资助金额:$42.06万
-
财政年份:2010
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury
-
批准号:8391741
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2010
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury
-
批准号:8050391
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2010
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injury
-
批准号:8586889
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2010
-
负责人:BHAGAVATULA MOORTHY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: